Dhanya Dharman | Pharmacology | Best Research Article Award

Published on by Best Paper Awards

Best Research Article Award

Dhanya Dharman
Dr Moopens College of Pharmacy, India
Paper Title: Effectiveness of mometasone, indacaterol, glycopyrronium (once daily single inhaler triple therapy) in the management of severe asthma: a prospective observational study

Dhanya Dharman
Affiliation Dr Moopens College of Pharmacy
Country India
Documents 53
Citations 37
h-index 4
Subject Area Pharmacology
Event International Research Excellence and Best Paper Awards
Google Scholar GausjtcAAAAJ&hl=en

Dhanya Dharman is a researcher affiliated with Dr Moopens College of Pharmacy, India, whose scholarly record includes 53 documents and 37 citations, with a reported h-index of 4. The research profile is situated within pharmacology and includes work examining therapeutic approaches for severe asthma, including single-inhaler triple therapy. [1]

Abstract

Dhanya Dharman is a pharmacology researcher affiliated with Dr Moopens College of Pharmacy in India. Her documented research profile comprises 53 scholarly documents, 37 citations, and an h-index of 4. A relevant research contribution examines the effectiveness of mometasone, indacaterol, and glycopyrronium, administered once daily through a single inhaler, for managing severe asthma. The prospective observational study addresses clinical treatment effectiveness within a real-world patient context and contributes to evidence concerning inhaled corticosteroid, long-acting beta2-agonist, and long-acting muscarinic antagonist combinations. The work reflects an applied pharmacological perspective focused on therapeutic management, treatment response, and respiratory disease care. [1]

Keywords

Severe asthma; triple therapy; mometasone; indacaterol; glycopyrronium; inhaler therapy; pharmacology; respiratory medicine; prospective observational study; asthma management.

Introduction

Severe asthma can require intensified pharmacological management when conventional treatment does not provide adequate control. Inhaled corticosteroids combined with long-acting bronchodilators are established therapeutic approaches, while triple therapy adds a long-acting muscarinic antagonist. The submitted study investigates this combination in a prospective observational setting. [1]

Research Profile

The supplied bibliometric record identifies 53 documents, 37 citations, and an h-index of 4 for Dhanya Dharman. These indicators provide a quantitative description of indexed scholarly output and citation activity, although bibliometric measures should be interpreted alongside publication quality, research context, authorship, and field-specific citation practices. [1]

Research Contributions

The principal research contribution identified for this recognition concerns the prospective observational assessment of once-daily single-inhaler triple therapy containing mometasone, indacaterol, and glycopyrronium. The study focuses on severe asthma management and provides clinical observations relevant to evaluating combined inhaled pharmacotherapy in routine treatment environments. [2]

Publications

The supplied record reports 53 documents associated with the researcher. The specifically identified paper is titled Effectiveness of mometasone, indacaterol, glycopyrronium (once daily single inhaler triple therapy) in the management of severe asthma: a prospective observational study. Complete bibliographic metadata, including journal, publication year, DOI, and author list, was not supplied and should therefore be verified before formal citation. [1]

Research Impact

The reported 37 citations indicate that the research output has received scholarly references in subsequent literature. Citation counts are indicators of academic visibility rather than direct measures of clinical effectiveness or societal benefit. The identified asthma research may be relevant to discussions of inhaled triple therapy and severe respiratory disease management. [1]

Award Suitability

The documented research aligns with the academic scope of a Best Research Article Award through its focus on a defined pharmacological intervention and a clinically relevant respiratory condition. Consideration may include methodological design, clarity of objectives, evidence quality, originality, relevance to pharmacology, and the completeness of supporting publication documentation. [2]

Conclusion

Dhanya Dharman’s supplied research profile documents scholarly activity in pharmacology and includes research addressing severe asthma treatment. The identified prospective observational study examines once-daily single-inhaler triple therapy involving mometasone, indacaterol, and glycopyrronium. Its subject focus provides a relevant basis for academic recognition within pharmacological and respiratory research. [1]

References

    1. Ramesan, R. (n.d.). Google Scholar profile. Google Scholar.
      Google Scholar Profile

    2. The era of pharmacovigilance and the need of pharmacovigilance in psychiatry: A review.
      https://www.researchgate.net/publication/331268791_The_era_of_pharmacovigilance_and_the_need_of_pharmacovigilance_in_psychiatry_A_review

    3. A cross sectional study of polycystic ovarian syndrome among pharmacy students.
      https://www.researchgate.net/publication/339282966_A_cross_sectional_study_of_polycystic_ovarian_syndrome_among_pharmacy_students

Mukesh Ratnaparkhi | Pharmacology | Best Researcher Award

Published on by Best Paper Awards

Dr. Mukesh Ratnaparkhi | Pharmacology | Best Researcher Award 

Professor | Marathwada Mitramandals College of Pharmacy | India

Dr. Mukesh P. Ratnaparkhi, a distinguished pharmaceutical scientist with over 19 years of academic and research experience, demonstrates strong suitability for a Best Researcher Award through his extensive contributions to pharmaceutics, drug delivery systems, and formulation science. Currently serving as a Professor in Pharmaceutics at Marathwada Mitra Mandal’s College of Pharmacy, Pune, he has progressed through roles of increasing responsibility and is an approved Associate Professor, postgraduate teacher, and Ph.D. research guide under Savitribai Phule Pune University. His academic foundation includes a Ph.D. in Pharmaceutical Sciences and a Master’s degree in Pharmaceutics, complementing his long-standing commitment to research. Dr. Ratnaparkhi has an impressive research portfolio with 74 publications in reputed Scopus, Web of Science, UGC Care, and international indexed journals, addressing critical pharmaceutical challenges such as solubility enhancement, nanoformulations, targeted pulmonary delivery, nasal drug delivery, and advanced drug dispersion techniques. His work spans nanosponge systems, nanoemulgels, cubosomes, solid dispersions, and dry powder inhalation formulations, signifying his expertise in innovative and translational drug delivery approaches. He holds four patents (three granted and one filed), demonstrating originality and innovation, and has guided or collaborated on numerous research projects. Complementing his publication record, he has delivered 31 scientific presentations at national and international conferences, showcasing the continued relevance and impact of his research. His professional strengths include excellent communication, leadership, team management, and a strong research orientation, supported by early industrial training that broadened his practical understanding of pharmaceutical processes. With nearly two decades of academic service, consistent research productivity, significant innovation, mentorship roles, and contributions that influence modern drug delivery systems, Dr. Ratnaparkhi exemplifies the qualities of a high-impact researcher and stands as a strong candidate for the Best Researcher Award.

Profiles: Google Scholar | ORCID | Scopus | ResearchGate | LinkedIn

Featured Publications

  1. Ratnaparkhi, M. P., & Suryawanshi, A. N. (2025). Development and characterization of novel cilnidipine-loaded nanosponge formulations. International Journal of Drug Delivery Technology, 15(3), 1198–1204.

  2. Kshirsagar, S. D., & Ratnaparkhi, M. (2025). Formulation and evaluation of propolis loaded nanosponges based topical anti-inflammatory gel. Indian Journal of Pharmaceutical Education and Research, 59(4), 1–11.

  3. Tekade, A., Ratnaparkhi, M., Shewale, A., Shinde, R., Kulkarni, G., & Pawar, P. (2025). Design and assessment of in situ nasal gel incorporated with nanostructured cubosomes for the targeted therapy of schizophrenia. Journal of Research in Pharmacy, 29(3), 947–958.

  4. Ratnaparkhi, M., Binawade, B., Salvankar, S., Aswar, M., Jadhav, P., Parhad, P., Bhangare, S., & Dalvi, S. (2025). Intravaginal administration of metformin HCl loaded nanoemulgel for treatment of PCOS: In-vitro and in-vivo study. Brazilian Journal of Pharmaceutical Sciences.

  5. Ratnaparkhi, M. P., Tekade, A. R., Salvankar, S. S., Dalvi, S. D., Kulkarni, G. M., & Markand, M. G. (2025). RP-HPLC method development and validation for the quantification of remdesivir IV formulation. Indian Drug, 62(6), 45–49.

Dr. Ratnaparkhi’s research advances innovative drug-delivery systems that enhance therapeutic efficiency and patient outcomes. His work contributes to modern pharmaceutical science by translating nanotechnology-based formulations into practical healthcare solutions with global impact.

Brandon Brooks | Medicine and Dentistry | Innovation Trailblazer Award

Published on by Best Paper Awards

Dr. Brandon Brooks | Medicine and Dentistry | Innovation Trailblazer Award

DPM, MPH at Columbia VA Health Care System, United States

Dr. Brandon M. Brooks is an accomplished podiatric physician, public health researcher, and academic leader whose career reflects a strong blend of clinical excellence, innovative research, and community service. He earned his Doctor of Podiatric Medicine from Barry University and a Master of Public Health from Dartmouth’s Geisel School of Medicine, where he was awarded the Henry Masters Award for academic and research distinction. His expertise lies in limb preservation, opioid prescribing practices, and the integration of mental health in podiatric care, leading to groundbreaking frameworks such as the Saint Dymphna Modification and Saint Brendan’s Guide. Dr. Brooks has authored numerous award-winning studies, served in leadership roles within the American College of Podiatric Medicine and the American Limb Preservation Society, and continues to mentor, teach, and inspire through his dedication to advancing patient care and public health.

Professional Profile

Google Scholar

Education

Dr. Brandon M. Brooks pursued a Bachelor of Science in Biology at Saint Leo University, where he distinguished himself as a scholar and leader, earning recognition as one of the youngest alumni to receive high professional honors. He then earned his Doctor of Podiatric Medicine from Barry University School of Podiatric Medicine, where he was recognized for his academic excellence, leadership qualities, and commitment to patient-centered care. He later completed a residency in podiatric medicine and surgery at the Charlie Norwood VA Medical Center, gaining extensive surgical experience and serving as chief resident. Building on this foundation, he completed a fellowship in podiatric public health at Dartmouth College and earned a Master of Public Health at the Geisel School of Medicine, focusing on epidemiology, biostatistics, and healthcare improvement.

Experience

Dr. Brooks has held key professional roles that reflect both clinical expertise and administrative leadership. As a podiatrist at the Columbia VA Health Care System, he provides advanced surgical and medical care for veterans, while also serving as Interim Chief of Podiatry where he restructured systems to improve access and quality of care. His earlier experience includes serving as an associate physician at Physicians Footcare, where he treated a wide range of complex foot and ankle conditions. He has also served as a teaching assistant at Dartmouth, supporting graduate-level instruction in epidemiology and health statistics. His leadership roles extend beyond clinical practice, including treasurer and board member of the American College of Podiatric Medicine, as well as contributions to national committees focused on education, advocacy, and clinical practice improvement.

Research Interest

Dr. Brooks’ research interests are centered on limb preservation, pain management, public health approaches in podiatry, and the integration of mental health in diabetic foot care. He has pioneered several innovative frameworks, such as the Saint Dymphna Modification to wound classification, which incorporates depression as a determinant of healing, and novel opioid prescribing guidelines tailored to foot and ankle surgery. His studies have addressed pressing issues including opioid misuse, postoperative pain outcomes, and patient-centered approaches to clinical decision-making. He is also passionate about bridging gaps between public health and podiatric medicine through large-scale studies, systematic reviews, and quality improvement projects. His work consistently emphasizes practical, evidence-based solutions that improve patient outcomes and influence national practice guidelines.

Awards and Honors

Dr. Brooks has received numerous awards that recognize his leadership, innovation, and academic contributions. At Dartmouth, he was honored with the Henry Masters Award for his lasting impact on healthcare and excellence in his Master of Public Health program. His research has earned multiple first-place poster awards at major conferences, including the American Podiatric Medical Association and the American Society of Podiatric Surgeons, for groundbreaking studies on opioid prescribing, limb preservation, and the intersection of depression with diabetic foot disease. He has also been recognized with distinguished alumni awards from Saint Leo University, as well as monetary awards for exceptional service at the Veterans Affairs Health System. These accolades reflect his ability to translate research into meaningful change in both clinical and community settings.

Research Skill

Dr. Brooks possesses advanced research skills that span quantitative and qualitative methodologies, including cross-sectional studies, systematic reviews, data analysis, and quality improvement initiatives. He is highly skilled in epidemiology and biostatistics, applying these competencies to investigate health disparities, prescribing practices, and patient-centered outcomes. His ability to design innovative frameworks, such as opioid prescribing models and novel classification systems, demonstrates creativity and scientific rigor. He has experience mentoring students in research design, statistical analysis, and academic writing, contributing to the development of future healthcare scholars. Additionally, his role as a peer reviewer for leading journals underscores his expertise in critically appraising scientific literature. These skills, combined with his clinical insight, enable him to conduct impactful research that directly informs practice and policy in podiatric medicine and public health.

Publication Top Notes

Title: Diagnostic accuracy of magnetic resonance imaging (MRI) versus dynamic ultrasound for plantar plate injuries: A systematic review and meta-analysis
Authors: RH Albright, BM Brooks, M Chingre, EE Klein, LS Weil Jr, AE Fleischer
Year: 2022
Citation: European Journal of Radiology, 152:110315

Title: Postoperative opioid-prescribing practice in foot and ankle surgery
Authors: BM Brooks, AE Fleischer, RG Smith, RH Albright
Year: 2023
Citation: Journal of the American Podiatric Medical Association, 113(5)

Title: The Diabetic Foot–Pain–Depression Cycle: A Multidisciplinary Cohort Study
Authors: BM Brooks, CD Shih, DE Tower, TT Tran, JE Simon, et al.
Year: 2023
Citation: Journal of the American Podiatric Medical Association, 113(3)

Title: Cognitive Bias in Postoperative Opioid-Prescribing Practice: A Novel Effect
Authors: BM Brooks, CD Shih, RWR Bratches, AS Arp, GJ Coughlin, KB Wolff, et al.
Year: 2023
Citation: Journal of the American Podiatric Medical Association, 113(3)

Title: Postprocedural Opioid-Prescribing Practice in Nail Surgery: A National, Questionnaire-Based, Cross-Sectional Study with Recommendations
Authors: BM Brooks, Q Li, AE Fleischer, NA Anderson, AZ Handa, CD Shih
Year: 2023
Citation: Journal of the American Podiatric Medical Association, 113(3)

Title: Opioid-Prescribing Approaches—One-Size-Fits-All versus Patient-Centric and Procedure-Focused—Among Podiatric Physicians: A Cross-Sectional Study
Authors: BM Brooks, RWR Bratches, KB Wolff, MD Stapp, KW Bruce, DE Tower
Year: 2023
Citation: Journal of the American Podiatric Medical Association, 113(4)

Title: The opioid use agreement in foot and ankle surgery: an addition to your informed consent
Authors: BM Brooks, NL Salvo, JM Robbins
Year: 2023
Citation: Journal of the American Podiatric Medical Association, 113(4)

Title: Evidence-based opioid education that reduces prescribing: The 10 principles of opioid prescribing in foot and ankle surgery
Authors: CP Ryans, BM Brooks, DE Tower, JM Robbins, ML Butterworth, MD Stapp, et al.
Year: 2024
Citation: The Journal of Foot and Ankle Surgery, 63(2):214–219

Title: Podiatry and the opioid epidemic: a call to action
Authors: BM Brooks
Year: 2023
Citation: Journal of the American Podiatric Medical Association, 113(4)

Title: American podiatric surgeons’ postoperative multimodal analgesic-prescribing practice: A 2019–2020 national survey
Authors: BM Brooks, RWR Bratches, AM Nettles, AE Fleischer, et al.
Year: 2023
Citation: Journal of the American Podiatric Medical Association, 113(4)

Title: The anesthetic effects of lidocaine with epinephrine in digital nerve blocks: a systematic review
Authors: AS Arp, JK Multani, RW Yen, BM Brooks
Year: 2023
Citation: Journal of the American Podiatric Medical Association, 113(4)

Title: Depression: the fourth pillar of classifying risk of diabetes-related amputation in veterans
Authors: BM Brooks, J Banks, AS Arp, V Saysoukha, et al.
Year: 2023
Citation: Journal of Psychiatry and Psychiatric Disorders, 7:201

Title: Diabetes-Related Extremity Amputation Depression and Distress (DREADD): A Multimethod Study
Authors: LM Brooks, BM Brooks, AS Arp, CR Dove, LC Rogers, R Michel, V Clinton, et al.
Year: 2025
Citation: Seminars in Vascular Surgery, 38(1):94–100

Title: Social pain: A systematic review on interventions
Authors: BM Brooks, FJ Cordero, SL Alchermes
Year: 2025
Citation: F1000Research, 14:58

Title: Concomitant Use of Spasmolytics and Opioids for Postoperative Pain After Foot and Ankle Surgery: Fair or Foul?
Authors: BM Brooks, RG Smith
Year: 2023
Citation: Journal of the American Podiatric Medical Association, 113(5)

Title: Diabetes Psychiatry: The Missing Piece of the Puzzle to Prevent Complications of the Diabetes Pandemic
Authors: BM Brooks, AM Nettles
Year: 2025
Citation: Psychoactives, 4(2):13

Title: Social Pain and Opioid Misuse: A Synergistic Epidemic (Syndemic)
Authors: BM Brooks, MI Brown, V Clinton, FJ Cordero, ML Butterworth
Year: 2025
Citation: IntechOpen

Title: Baseline Knowledge of Peripheral Arterial Disease and Factors Influencing Learning Material Preferences in the San Francisco Chinese-Speaking Community: A Survey Analysis
Authors: CD Shih, T Lee, S Hassan, H Chau, BM Brooks, B Zhang, ER Rosario
Year: 2024
Citation: Journal of Vascular Diseases, 4(1):1

Title: Postoperative Opioid-Prescribing Practice in Limb Preservation Surgery
Authors: BM Brooks, CD Shih, RWR Bratches, KT Pham, L Hooshivar, et al.
Year: 2024
Citation: Journal of the American Podiatric Medical Association, 114(2)

Title: Misdiagnosis or Missed Diagnosis-Hallux Sesamoid Fractures among Active-Duty Females in the United States Air Force: A Case Series
Authors: BM Brooks, KB Wolff
Year: 2024
Citation: Unpublished / Case Series Report

Title: A Book Review of Dopesick: Dealers, Doctors, and the Drug Company that Addicted America by Beth Macy
Authors: BM Brooks
Year: 2023
Citation: Journal of the American Podiatric Medical Association, 113(5)

Title: Winners of the Student/Resident Poster Contest 2018
Authors: B Brooks, K Pham, S Saeedi
Year: 2019
Citation: Linacre Quarterly, 86(2–3):254–257

Conclusion

Dr. Brooks exemplifies a professional who bridges the worlds of clinical practice, research innovation, and leadership with distinction. His strong educational foundation, extensive clinical experience, and groundbreaking research have contributed to redefining approaches in limb preservation, pain management, and podiatric public health. His numerous awards highlight his influence as both a practitioner and innovator, while his professional memberships and leadership positions reflect his commitment to advancing the field at national and international levels. With his unique ability to integrate patient care, academic excellence, and health systems improvement, he continues to inspire peers and trainees. Dr. Brooks stands out as a forward-thinking leader whose contributions will shape the future of podiatric medicine and public health, positioning him as a role model and trailblazer.